Minoryx Therapeutics and Palobiofarma receive the 2016 Biosuccess Award Blog Post

The Catalan Association of Biotechnology Companies (CataloniaBio) has recognized with the Biosuccess Award of the Year two companies associated with the Barcelona Science Park (PCB): Minoryx Therapeutics, which has just finished setting up their lab facilities at PCB, and Palobiofarma, which was based at the Parc from 2010 to 2013. The award giving ceremony was held yesterday at Palau de Pedralbes under his winter networking event CataloniaBio Gala Dinner, which this year coincided with the 10th anniversary and gathered more than 250 entrepreneurs, investors, researchers and professionals from the fields of the life sciences and health. 

 

A study with the participation of CNAG shows that Neanderthals and modern humans crossbred much earlier than was previously thought Blog Post

An international research team has find first genetic evidence of modern human DNA in a Neanderthal individual. The discovery –published in Nature– confirms the interbred between Homo sapiens and Homo neanderthalensis and suggests that it happened 100.000 years ago, before the 65.000 years ago previously documented. This earlier genetic exchange, which may have taken place in the Near East, has not been detected in European Neanderthals. The study, led by the Max Planck German Institute, counts among its authors with researchers of CNAG-CRG located at the Barcelona Science Park (PCB).  

 

The University of Barcelona sets up a crowdfunding platform Blog Post

The University of Barcelona (UB), through the Barcelona Institute of Entrepreneurship (BIE), has launched a crowdfunding platform to promote solidarity or research projects that do not receive public funding. The first call has been announced this month of February in collaboration with Verkami. Three projects will compete to achieve the financial resources that they need. The initiative is part of the strategic plan of the BIE– promoted by the UB and Bosch and Gimpera Foundation (FBG), from its headquarters offices at the PCB–with the aim of making tools and resources available to entrepreneurs within the framework of Group UB.

 

Biotech Aromics obtains the seal ‘Innovative SME’ Blog Post

The Ministry of Economy and Competitiveness recently awarded the biotech Aromics the seal of ‘Pyme Innovadora‘ ( Innovative SME)The company -founded in 2005 and specialized in the application of omic sciences in the research and development of new drugs and diagnostic methods- was part of the first generation of companies that participated in the Bioincubator project at the Barcelona Science Park (PCB).

 

Jordi Naval: “I think both researchers and companies should expand their scope of vision and ask themselves where they are headed” Blog Post

Jordi Naval takes over the management of Fundació Bosch i Gimpera (FBG) with a clear objective: building a climate of trust and interaction among researchers, investors and the productive fabric. A very ambitious challenge that Naval faces with the skill and resolution that his double ‘expertise’ as both, a scientist and entrepreneur, has given him.

 

The 4th edition of the ‘Crazy about Biomedicine’ kicks off Blog Post

On Saturday, the 24 students chosen from more than 200 applicants for the ‘Crazy about Biomedicine course‘ at IRB Barcelona will have their first theory class in the centre, with the collaboration of the Barcelona Science Park (PCB). In fact, the success of first course in this field of science in 2013, an initiative of IRB Barcelona, led the Catalunya–La Pedrera Foundation to increase the number of disciplines on offer and to set up new courses, all of which fall under the umbrella of the ‘Crazy about Science Programme‘.